Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

View:
Post by antoninus on Mar 30, 2010 12:40pm

isaloser

despite some here not liking what he has to say, he does raise a few decent points.
 
the sweatshirt thing may seem trivial, but it matters. toally unprofessional. I noticed it too right away and thought, what were you thinking?  

as for the wording of the release, it was lacking and left certain negatives , albeit I'm sure unintended.
Comment by BornReady1970 on Mar 30, 2010 1:42pm
I would agree that the article dampend what should have been a great day based on the FDA acceptance. Funny thing is, is he probably thought he was helping.
Comment by WASKERWISK on Mar 30, 2010 2:12pm
Huh? What on earth are you guys talking about?  the article was fine, very good in fact and as somone has already pointed out gave what I thought was soem useful and better insight into what has gone on before and what the plans are exactly.  How did it dampen anything?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities